LBPH(Delisted)
Longboard·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LBPH
Longboard Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases
4275 Executive Square, Suite 950, La Jolla, CA 92037
--
Longboard Pharmaceuticals, Inc., was incorporated in Delaware on January 3, 2020. The company is a clinical-stage biopharmaceutical company focused on the development of novel, transformative medicines for neurological diseases.
Company Financials
EPS
LBPH has released its 2024 Q3 earnings. EPS was reported at -0.63, versus the expected -0.58, missing expectations. The chart below visualizes how LBPH has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
